J
Joshua D Hack
Researcher at West Virginia University
Publications - 11
Citations - 156
Joshua D Hack is an academic researcher from West Virginia University. The author has contributed to research in topics: Radiosurgery & Meningioma. The author has an hindex of 4, co-authored 11 publications receiving 80 citations.
Papers
More filters
Journal ArticleDOI
Stereotactic Radiosurgery for Brainstem Metastases: An International Cooperative Study to Define Response and Toxicity.
Daniel M. Trifiletti,Cheng-Chia Lee,Hideyuki Kano,Jonathan Cohen,James Janopaul-Naylor,Michelle Alonso-Basanta,John Y K Lee,Gabriela Simonova,Roman Liscak,Amparo Wolf,Svetlana Kvint,Inga S. Grills,M.D. Johnson,Kang Du Liu,Chung Jung Lin,David Mathieu,Danilo Silva,Mayur Sharma,Christopher P. Cifarelli,Christopher N. Watson,Joshua D Hack,John G. Golfinos,Douglas Kondziolka,Gene Barnett,L. Dade Lunsford,Jason P. Sheehan +25 more
TL;DR: This study provides additional evidence that SRS has become an option for patients with brainstem metastases, with an excellent benefit-to-risk ratio in the hands of experienced clinicians, and increases the risk of severe toxicity in brain stem metastasis patients undergoing SRS.
Journal ArticleDOI
Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study
Christopher P. Cifarelli,Stefanie Brehmer,John A. Vargo,Joshua D Hack,K.H. Kahl,Gustavo Sarria-Vargas,Frank A. Giordano +6 more
TL;DR: IORT is a safe and effective means of delivering adjuvant radiation to the BM resection cavities with high rates of LC and low incidence of RN, and further studies are warranted directly comparing LC outcomes to SRS.
Journal ArticleDOI
Feasibility of dose escalation using intraoperative radiotherapy following resection of large brain metastases compared to post-operative stereotactic radiosurgery.
John A. Vargo,Kristie M. Sparks,Rahul Singh,Geraldine M. Jacobson,Joshua D Hack,Christopher P. Cifarelli +5 more
TL;DR: Critical organ dosimetry for IORT remains generally lower than that achieved with single fraction SRS following resection of large brain metastases, and is recommended 30 Gy to surface as the preferred prescription, consistent with the dose recommendation in glioblastoma used in the ongoing INTRAGO-II phase-III trial.
Journal ArticleDOI
Feasibility of Dose Escalation Using Intraoperative Radiotherapy Following Resection of Large Brain Metastases Compared to Post-Operative Stereotactic Radiosurgery
Journal ArticleDOI
Stereotactic Radiosurgery for Perioptic Meningiomas: An International, Multicenter Study
Adomas Bunevicius,Rithika Kormath Anand,Mohanad Suleiman,Ahmed M. Nabeel,Wael A. Reda,Sameh R. Tawadros,Khaled Abdelkarim,Amr M N El-Shehaby,Reem M Emad,Tomas Chytka,Roman Liscak,Kimball Sheehan,Darrah Sheehan,Marco Perez Caceres,David Mathieu,Cheng-Chia Lee,Huai-che Yang,Piero Picozzi,Andrea Franzini,Luca Attuati,Herwin Speckter,Jeremy Olivo,Samir Patel,Christopher P. Cifarelli,Daniel T Cifarelli,Joshua D Hack,Ben A. Strickland,Gabriel Zada,Eric L. Chang,Kareem R Fakhoury,Chad G. Rusthoven,Ronald E Warnick,Jason P. Sheehan +32 more
TL;DR: In this paper, the safety and effectiveness of Stereotactic radiosurgery (SRS) for perioptic meningiomas was evaluated in 12 institutions participating in the International Radiosurgery Research Foundation (IRRF).